Dear [Dr/Doctor/Miss/Mr/Mrs/Ms/blank] [First Name/Last Name][, MD/, PharmD/, PA/, NP/, DO/blank], I am happy to share with you that earlier this week Scholar Rock resubmitted our Biologics License Application for our spinal muscular atrophy (SMA) investigational treatment. We
anticipate an FDA decision in 2026 and look forward to serving the SMA community. [Please find additional details
here./For additional details, please see our press release.] Best,
[Representative first name and last name]
[Representative email address] [Representative phone number] | 
